This webinar focuses on the application of high flow in PACU, and the transfer of patients into the ward while maintaining the therapy.

Signup image for course

Webinar Series

This webinar is the third in a series on Nasal High Flow Therapy brought to you through a collaboration between Critical Care Education and Fisher & Paykel Healthcare. Your webinar host Ken Hambrecht will be joined by educators from Fisher & Paykel Healthcare to bring you the latest evidence and clinical application of Nasal High Flow Therapy in various hospital areas.

About this Webinar

This webinar focuses on the application of high flow in PACU, and the transfer of patients into the ward while maintaining the therapy. This relatively new PACU therapy is explained and a summary of the evidence is presented.

Emerging evidence suggests application of nasal high flow therapy in PACU significantly improves recovery and outcomes for those patients who require a degree of respiratory support. The combination of high flows, humidification and the ability to titrate oxygen provides physiological benefits the application of traditional oxygen therapy just cannot provide.

Topics covered:

  • Identification of patients with respiratory compromise in PACU
  • Effective utilisation of high flow – what flow? What O2?
  • Maintenance of the therapy into the ward
  • Clinical evidence to support the use of this therapy in certain patient groups

Other Webinars in this Series

Webinar 1:  Nasal High Flow Therapy – Physiological Mechanisms

Webinar 2: Nasal High Flow Therapy - Paediatric Applications

Presented by

In collaboration with

This webinar is sponsored by Fisher & Paykel Healthcare.

Loading...